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The development of Kaposi’s sarcoma (KS), the most
common malignancy in AIDS patients, results from
Kaposi’s sarcoma-associated herpesvirus (KSHV) infec-
tion of endothelial cells and subsequent induction of pro-
liferation, angiogenesis, and inflammation. Previously, we
demonstrated that KSHV infection of human umbilical
vein endothelial cells (HUVEC) induced a transcriptional
induction of Angiopoietin-2 (Ang-2), a pro-angiogenic
and pro-inflammatory cytokine that is highly present in
KS tumors. This transcriptional up-regulation of Ang-2
started at 12 h and peaked at 54 h post-infection. In dif-
ference to our previous data, here we demonstrate that
KSHV infection of HUVEC induces rapid release of Ang-
2 within minutes of viral contact. Pre-made Ang-2 is
stored in the Weibel-Palade body in endothelial cells and
is released through regulated exocytosis. KSHV binding
to HUVEC is responsible for rapid Ang-2 release because
blockade of viral binding inhibits this cytokine exocytosis.
We find that KSHV binding to its integrin receptors on
endothelial cells activates the integrin tyrosine kinase
receptors signaling pathways, including tyrosine phos-
phorylation of the kinases FAK and Src, and triggers
rapid calcium mobilization. This mobilization likely plays
a key role in mediating Ang-2 release, as its inhibition by
various calcium chelators and calcium channel blockers
substantially reduces Ang-2 release. We also demonstrate
a direct interaction and association of the kinase Src with
the alpha1C subunit of L-type calcium channel. Indeed,
specific inhibitors of protein tyrosine phosphorylation
not only disrupt this interaction but also abolish Ang-2
release. Finally, preliminary data from in vitro cell adhe-
sion assays suggest that this rapidly released Ang-2
enhances migration and adhesion of monocytes to the
infected endothelial cells. To our knowledge, this is the
first demonstration of interaction between KSHV and its
integrins receptors in regulating rapid cytokine release.
This study also uncovers a novel mechanism of KSHV
induction of angiogenesis and inflammation, which is
much faster, and could likely play important roles in the
early event of KS tumor development.
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